← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2019Last known activity
Apr 1, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 3 (4 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (9)
- NCT04870502Lead sponsorPhase 2/Phase 3Apr 1, 2019
- NCT04870502Overall official - principal investigatorPhase 2/Phase 3Apr 1, 2019
- NCT04870502Reponsible party - principal investigatorPhase 2/Phase 3Apr 1, 2019
- NCT05594186Lead sponsorN/AMar 1, 2019
- NCT05594186Overall official - principal investigatorN/AMar 1, 2019
- NCT05594186Reponsible party - principal investigatorN/AMar 1, 2019
- NCT04852510Lead sponsorPhase 2/Phase 3Feb 1, 2019
- NCT04852510Overall official - principal investigatorPhase 2/Phase 3Feb 1, 2019
- NCT04852510Reponsible party - principal investigatorPhase 2/Phase 3Feb 1, 2019
Details
- Last known activity
- Apr 1, 2019